This is the first FDA-approved, blood-based genetic test that can detect epidermal growth factor receptor (EGFR) gene mutations in non-small cell lung cancer patients.

这是FDA批准的首个能够检测非小细胞肺癌患者表皮生长因子受体(EGFR)基因突变的、以血液为基础的基因检测试剂盒。

youdao

Permitting the non-disclosure of a pivotal risk factor, such as a genetic-test result, would undermine one of the fundamentals of insurance.

ECONOMIST: Testing times | The